XML 24 R14.htm IDEA: XBRL DOCUMENT

Liquidity	6 Months Ended
Jun. 30, 2025
Liquidity
Liquidity	Note 8. Liquidity During the six months ended June 30, 2025, the Company used $1,575,000 in operations. As of June 30, 2025, the Company had $2,101,000 of working capital, including $712,000 in cash. The Company has a history of operating losses and negative cash flow, which are expected to improve with growth. As described more fully in Note 4, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability to procure certain products necessary to achieve our growth projections and in elevated legal costs. To mitigate the impact of procurement constraints, the Company builds inventory in anticipation of third quarter seasonal requirements, and has invested in materials necessary to carry out trials and initial production runs at new co-manufacturers. The Company secured a receivables-based line of credit in August 2024 of $1,500,000, with no outstanding borrowing as of June 30, 2025. Management expects that the cash cycle will shorten as additional contracted capacity improves production volume and efficiency in the second half of 2025. Additionally, in May 2024, the Company obtained non-recourse litigation financing to allow vigorous pursuit of the complaint against the Manufacturer without further expense to the Company. Finally, as described in Note 6, the Company raised $3,000,000 through the sale of the Company’s common stock in February 2025. The financial position at June 30, 2025 and historical results raise substantial doubt about the Company’s ability to continue as a going concern. As described, the Company has completed steps to mitigate dispute related issues and raise capital. The actions taken have resulted in the alleviation of the substantial doubt about the Company’s ability to continue as a going concern.

Liquidity

6 Months Ended

Jun. 30, 2025

Note 8. Liquidity

During the six months ended June 30, 2025, the Company used $1,575,000 in operations. As of June 30, 2025, the Company had $2,101,000 of working capital, including $712,000 in cash.

The Company has a history of operating losses and negative cash flow, which are expected to improve with growth. As described more fully in Note 4, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability to procure certain products necessary to achieve our growth projections and in elevated legal costs.

To mitigate the impact of procurement constraints, the Company builds inventory in anticipation of third quarter seasonal requirements, and has invested in materials necessary to carry out trials and initial production runs at new co-manufacturers. The Company secured a receivables-based line of credit in August 2024 of $1,500,000, with no outstanding borrowing as of June 30, 2025. Management expects that the cash cycle will shorten as additional contracted capacity improves production volume and efficiency in the second half of 2025. Additionally, in May 2024, the Company obtained non-recourse litigation financing to allow vigorous pursuit of the complaint against the Manufacturer without further expense to the Company. Finally, as described in Note 6, the Company raised $3,000,000 through the sale of the Company’s common stock in February 2025.

The financial position at June 30, 2025 and historical results raise substantial doubt about the Company’s ability to continue as a going concern. As described, the Company has completed steps to mitigate dispute related issues and raise capital. The actions taken have resulted in the alleviation of the substantial doubt about the Company’s ability to continue as a going concern.